Modern Healthcare: Rep. Tom Marino (R-Pa.) has withdrawn his name from consideration to lead the Office of National Drug Control Policy, according to President Donald Trump.
Trump announced Marino's decision on Twitter Tuesday morning, calling him "a fine man and a great congressman."
The move comes just days after an investigative report in CBS' "60 Minutes" and the Washington Post revealed Marino was a key sponsor of a 2016 bill that effectively weakened the U.S. Drug Enforcement Administration's ability to prevent companies from distributing opioids if they were suspected of suspicious activity.
On Monday, Trump raised the possibility of withdrawing Marino's nomination during a news conference.
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Nowi360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Now